Skip to main content

JPMORGAN CHASE & CO

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 19617 NEW YORK, NY

Position in VRTX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$3,140,585,469
+$402,526,373 QoQ
Shares Held
7,033,156
+16.5% QoQ
Ownership
2.77%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 88.06883966015252.ToString("F0")% Shared 0.9568252086012607.ToString("F0")% None 10.97433513124622.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,634,665 across 404 Biotechnology names. VRTX ranks #3 (18.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
7,033,156 $3,140,585,469

All Filings in VRTX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,140,585,469 7,033,156
2025-12-31 $2,738,059,096 6,039,481
2025-09-30 $2,520,116,446 6,434,778
2025-06-30 $2,613,039,508 5,869,361
2025-03-31 $3,760,091,799 7,755,645
2024-12-31 $2,542,288,178 6,313,107
2024-09-30 $3,222,347,232 6,928,587
2024-06-30 $3,093,451,216 6,599,785
2024-03-31 $2,515,636,005 6,018,124
2023-12-31 $2,288,457,177 5,624,265
2023-09-30 $2,123,248,966 6,105,852
2023-06-30 $2,095,808,794 5,955,525
2023-03-31 $2,004,084,014 6,360,758
2022-12-31 $1,585,520,014 5,490,408
2022-09-30 $1,407,073,766 4,859,687
2022-06-30 $1,475,886,954 5,237,542
2022-03-31 $1,255,962,221 4,812,669
2021-12-31 $980,367,084 4,464,331
2021-09-30 $763,966,061 4,211,732
2021-06-30 $894,846,638 4,438,063
2021-03-31 $689,001,798 3,206,300
2020-12-31 $611,653,584 2,588,024
2020-09-30 $609,497,089 2,239,810
2020-06-30 $613,449,989 2,113,086
2020-03-31 $522,246,703 2,194,775